Combined GSTP1 and NQO1 germline polymorphisms in the susceptibility to Multiple Sclerosis

References

• Compston A, Coles A. Multiple sclerosis. Lancet 2002;359:1221–31.
   PubMed Web of Science ®Google Scholar
• Haider L, Fischer MT, Frischer JM, Oxidative damage in multiple sclerosis lesions. Brain 2011;134:1914–24.
   PubMed Web of Science ®Google Scholar
• Gilgun-Sherki Y, Melamed E, Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 2004;251:261–8.
   PubMed Web of Science ®Google Scholar
• Schreibelt G, van Horssen J, van Rossum S, Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res Rev 2007;56: 322–30.
   PubMedGoogle Scholar
• Gonsette RE. Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity. J Neurol Sci 2008;274:48–53.
   PubMed Web of Science ®Google Scholar
• Ali-Osman F, Akande O, Antoun G, Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997;272:10004–12.
   PubMed Web of Science ®Google Scholar
• Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445–600.
   PubMed Web of Science ®Google Scholar
• Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defense against oxidative stress. Free Radic Res 1999;31:273–300.
   PubMed Web of Science ®Google Scholar
• Strange RC, Jones PW, Fryer AA. Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett 2000; 112–3:357–63.
   Web of Science ®Google Scholar
• Tajouri L, Mellick AS, Ashton KJ, Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis. Brain Res Mol Brain Res 2003;119:170–83.
   PubMedGoogle Scholar
• Morrow CS, Cowan KH, Goldsmith ME. Structure of the human genomic glutathione S-transferase-pi gene. Gene 1989;75:3–11.
   PubMed Web of Science ®Google Scholar
• Zimniak P, Nanduri B, Pikuła S, Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem 1994;224:893–9.
   PubMedGoogle Scholar
• Johansson AS, Stenberg G, Widersten M, Structure-activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105. J Mol Biol 1998;278:687–98.
   PubMed Web of Science ®Google Scholar
• Watson MA, Stewart RK, Smith GB, Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998;19:275–80.
   PubMed Web of Science ®Google Scholar
• Siegel D, Gustafson DL, Dehn, DL, NAD(P)H: quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 2004;65:1238–47.
   PubMed Web of Science ®Google Scholar
• Traver RD, Horikoshi T, Danenberg KD, NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res 1992;52:797–802.
   PubMed Web of Science ®Google Scholar
• Stavropoulou C, Zachaki S, Alexoudi A, The C609T inborn polymorphism in NAD(P)H:quinone oxidoreductase 1 is associated with susceptibility to multiple sclerosis and affects the risk of development of the primary progressive form of the disease. Free Rad Biol Med 2011;51:713–8.
   PubMed Web of Science ®Google Scholar
• McDonald WI, Comptson A, Edan G, Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121–7.
   PubMed Web of Science ®Google Scholar
• Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907–11.
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Disability rating scales in multiple sclerosis. Ann N Y Acad Sci 1984;436:347–60.
   PubMed Web of Science ®Google Scholar
• Hawkins SA, McDonnell GV. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 1999;67:148–52.
   PubMed Web of Science ®Google Scholar
• Amato MP, Zipoli V, Goretti B, Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol 2006;253:1054–9.
   PubMed Web of Science ®Google Scholar
• Sayao AL, Devonshire V, Tremlett H. Longitudinal follow-up of “benign” multiple sclerosis at 20 years. Neurology 2007;68:496–500.
   PubMed Web of Science ®Google Scholar
• Costelloe L, Thompson A, Walsh C, Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease. J Neurol Neurosurg Psychiatry 2008;79:1245–8.
   PubMed Web of Science ®Google Scholar
• Portaccio E, Stromillo ML, Goretti B, Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology 2009;73:498–503.
   PubMed Web of Science ®Google Scholar
• Mastorodemos V, Nikolakaki H, Tzagournissakis M, Benign multiple sclerosis in Crete. Mult Scler 2010;16:701–6.
   PubMedGoogle Scholar
• Skoog B, Runmarker B, Winblad S, A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy. Brain 2012;135:900–11.
   PubMed Web of Science ®Google Scholar
• Harries LW, Stubbins MJ, Forman D, Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997;18:641–4.
   PubMed Web of Science ®Google Scholar
• Zachaki S, Stavropoulou C, Kalomoiraki M, Association of A313G glutathione S-transferase P1 germline polymorphism with susceptibility to de novo myelodysplastic syndrome. Leuk Lymphoma 2013;54:1756–61.
   PubMed Web of Science ®Google Scholar
• Hohaus S, Di Ruscio A, Di Febo A, Glutathione S-transferase P1 genotype and prognosis in Hodgkin's lymphoma. Clin Cancer Res 2005;11:2175–9.
   PubMed Web of Science ®Google Scholar
• Fabiani E, D'Alò F, Scardocci A, Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes. Leuk Res 2009;33:1068–71.
   PubMed Web of Science ®Google Scholar
• Maggini V, Buda G, Galimberti S, Lack of association of NQO1 and GSTP1 polymorphisms with multiple myeloma risk. Leuk Res 2008;32:988–90.
   PubMed Web of Science ®Google Scholar
• Kuźma M, Jamrozik Z, Barańczyk-Kuźma A. Activity and expression of glutathione S-transferase pi in patients with amyotrophic lateral sclerosis. Clin Chim Acta 2006;364:217–21.
   PubMed Web of Science ®Google Scholar
• Zuntar I, Kalanj-Bognar S, Topić E, The glutathione S-transferase polymorphisms in a control population and in Alzheimer's disease patients. Clin Chem Lab Med 2004;42:334–9.
   PubMed Web of Science ®Google Scholar
• Pinhel MA, Nakazone MA, Cação JC, Glutathione S-transferase variants increase susceptibility for late-onset Alzheimer's disease: association study and relationship with apolipoprotein E epsilon4 allele. Clin Chem Lab Med 2008;46:439–45.
   PubMed Web of Science ®Google Scholar
• Ming X, Johnson WG, Stenroos ES, Genetic variant of glutathione peroxidase 1 in autism. Brain Dev 2010;32:105–9.
   PubMed Web of Science ®Google Scholar
• Williams TA, Mars AE, Buyske SG, Risk of autistic disorder in affected offspring of mothers with a glutathione S-transferase P1 haplotype. Arch Pediatr Adolesc Med 2007;161:356–61.
   PubMedGoogle Scholar
• Wilk JB, Tobin JE, Suchowersky O, Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Neurology 2006;67:2206–10.
   PubMed Web of Science ®Google Scholar
• Mann CL, Davies MB, Boggild MD, Glutathione S-transferase polymorphisms in MS: their relationship to disability. Neurol 2000;54:552–7.
   PubMed Web of Science ®Google Scholar